Join Prof. Martin as he delivers an illuminating and engaging case study on early signs and symptoms in Alzheimer’s disease, relevance of genetic testing, therapeutic strategies and the importance of comprehensive patient / care giver information. The practical considerations of using biomarkers and amyloid-targeting drugs in AD are also discussed.
KOL Commentary